Abstract
This chapter discusses the dimensions and determinants of postpatent entry of generic medicines into the pharmaceutical markets in developing countries. A variety of policies and regulatory measures relating to generic medicines entry are in place in developing countries. However, these policies are less robust, seem less coherent, and there are potential gaps between policy intent and implementation. The postpatent entry of generic medicines in developing countries is majorly determined by the prevailing regulatory policies and intellectual property rights, prepatent market size of the innovator products, generic firm's characteristics, and the existence and the degree of the entry-deterrence strategies by innovators, majority of which are derived from the patent system. Although the pattern of postpatent entry of generic medicines into the pharmaceutical markets in developing countries is similar to that in developed markets, the extent of generic entry and competition in developing countries appear limited.
Original language | English |
---|---|
Title of host publication | Social and Administrative Aspects of Pharmacy in Low-and Middle-Income Countries |
Subtitle of host publication | Present Challenges and Future Solutions |
Editors | Mohamed Izham Mohamed Ibrahim, Albert I. Wertheimer, Zaheer-Ud-Din Babar |
Place of Publication | London UK |
Publisher | Academic Press |
Chapter | 13 |
Pages | 211-225 |
Number of pages | 15 |
Edition | 1st |
ISBN (Electronic) | 9780128112298 |
ISBN (Print) | 9780128112281 |
DOIs | |
Publication status | Published - 2018 |
Externally published | Yes |
Keywords
- Competition
- Developing countries
- Entry barriers
- Generic medicines
- Generic medicines policy
- Market entry
- Patents
- Pharmaceuticals
- Regulation